Higher heart risk seen with Abbott dissolving stent after two years: study

Published 9y ago

Patients who received Abbott Laboratories’ novel dissolving vascular stent had a significantly higher rate of serious adverse heart events than those treated with the company’s widely used Xience drug-coated metal stent two years after implantation, according ... More »